Eosinophilic Lung Diseases.
Cottin V.
Immunol Allergy Clin North Am. 2023 May;43(2):289-322. doi: 10.1016/j.iac.2023.01.002.
Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.
Wechsler ME, Hellmich B, Cid MC, Jayne D, Tian X, Baylis L, Roufosse F.
J Allergy Clin Immunol. 2023 Jun;151(6):1415-1428. doi: 10.1016/j.jaci.2023.03.011. Epub 2023 Apr 21.
Eosinophilic Dermatoses: Recognition and Management.
Marzano AV, Genovese G.
Am J Clin Dermatol. 2020 Aug;21(4):525-539. doi: 10.1007/s40257-020-00520-4.
HES and EGPA: Two Sides of the Same Coin.
Khoury P, Akuthota P, Kwon N, Steinfeld J, Roufosse F.
Mayo Clin Proc. 2023 Jul;98(7):1054-1070. doi: 10.1016/j.mayocp.2023.02.013.
Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases.
Davis MDP, van der Hilst JCH.
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1162-1170. doi: 10.1016/j.jaip.2018.05.006. Epub 2018 Jun 2.
Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management.
Trivioli G, Terrier B, Vaglio A.
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii84-iii94. doi: 10.1093/rheumatology/kez570.
Benralizumab for eosinophilic granulomatosis with polyangiitis.
Cottu A, Groh M, Desaintjean C, Marchand-Adam S, Guillevin L, Puechal X, Beaumesnil S, Lazaro E, Samson M, Taille C, Durel CA, Diot E, Nicolas S, Guilleminault L, Ebbo M, Cathebras P, Dupin C, Yildiz H, Belfeki N, Pugnet G, Chauvin P, Jouneau S, Lifermann F, Martellosio JP, Cottin V, Terrier B; French Vasculitis Study Group.
Ann Rheum Dis. 2023 Dec;82(12):1580-1586. doi: 10.1136/ard-2023-224624. Epub 2023 Aug 7.
Hypereosinophilic syndromes.
Kahn JE, Blétry O, Guillevin L.
Best Pract Res Clin Rheumatol. 2008 Oct;22(5):863-82. doi: 10.1016/j.berh.2008.09.010.
Eosinophils and eosinophilic immune dysfunction in health and disease.
Jackson DJ, Akuthota P, Roufosse F.
Eur Respir Rev. 2022 Jan 25;31(163):210150. doi: 10.1183/16000617.0150-2021. Print 2022 Mar 31.
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
Pavord ID, Bel EH, Bourdin A, Chan R, Han JK, Keene ON, Liu MC, Martin N, Papi A, Roufosse F, Steinfeld J, Wechsler ME, Yancey SW.
Allergy. 2022 Mar;77(3):778-797. doi: 10.1111/all.15056. Epub 2021 Sep 16.
